AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2002 NOV 20 - (NewsRx.com & NewsRx.net) -- Avax Technologies, Inc., (NASDAQ:AVXT) announced it signed a Distribution Agreement with Ferrer Internacional, S.A. (Grupo Ferrer) for sales and distribution of the AC Vaccine Technology in Europe, Latin America, and certain Asian territories.
Avax will retain all manufacturing rights and will sell the vaccine to Grupo Ferrer. The exclusive distribution agreement calls for payments to be made to Avax for the manufacturing of the vaccine on a cost plus basis with an additional payment based upon the reimbursed cost of the vaccine. In addition, Avax will receive milestone payments upon the achievement of predefined marketing and registration goals. Product will be produced at the company's Lyon, France, manufacturing facility.
Rafael Foguet, Grupo Ferrer, commented, "We are very happy to have the opportunity to help make these important products available to patients in Europe and Latin America with cancer. With our ...
Source: HighBeam Research, Avax Technologies signs distribution agreement.(Brief Article)